Forma Therapeutics gets grant for USP30 inhibitor compounds for medical use
Pharmaceutical Technology
APRIL 1, 2024
Discover how Forma Therapeutics Inc's patent for USP30 Inhibitor Compounds paves the way for innovative pharmaceutical treatments, targeting specific structural configurations for effective patient care.
Let's personalize your content